Capricor Therapeutics Inc
CAPR
CAPR: Capricor Therapeutics Inc is a United States-based biotechnology company focused on the discovery, development, and commercialization of first-in-class biological therapies for the treatment of diseases, with a focus on Duchenne muscular dystrophy and other medical conditions. The company's development stage product pipeline includes CAP-1002, for Duchenne Muscular Dystrophy Program and COVID-19 Program; CDC-Exosomes (CAP-2003); and Exosome-mRNA vaccine.
moreShow CAPR Financials
Recent trades of CAPR by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by CAPR's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Followers on CAPR's company Twitter account
Number of mentions of CAPR in WallStreetBets Daily Discussion
Recent insights relating to CAPR
Recent picks made for CAPR stock on CNBC
ETFs with the largest estimated holdings in CAPR
Flights by private jets registered to CAPR